Skip to main content

Table 1 Baseline characteristics of patients completing the study a

From: Trapa bispinosa Roxb. extract lowers advanced glycation end-products and increases live births in older patients with assisted reproductive technology: a randomized controlled trial

Characteristic (unit) Hishi group (n = 32) Control group (n = 31)
Age (year) 38.9 ± 1.0 39.1 ± 0.9
Infertility duration (years) 2.8 ± 2.9 2.2 ± 2.3
Number of previous ART attempts 0.5 ± 0.7 0.2 ± 0.5
Gravidity 0.9 ± 1.0 1.1 ± 1.6
Parity 0.4 ± 0.6 0.4 ± 0.6
Body mass index (BMI, kg/m2) 21.6 ± 2.5 21.0 ± 2.3
Systolic / diastolic blood pressure (mm Hg) 108 ± 14 / 66 ± 8.4 108 ± 11 / 67 ± 7.7
Anti-Müllerian hormone (ng/mL) 2.96 ± 2.36 3.97 ± 4.25
Follicle-stimulating hormone on day 3 (IU/L) 6.8 ± 2.3 7.0 ± 3.0
Luteinizing hormone on day 3 (IU/L) 4.2 ± 1.9 4.9 ± 2.3
Prolactin (ng/mL) 9.8 ± 5.9 11.3 ± 8.9
Estradiol on day 3 (pg/mL) 49 ± 50 79 ± 108
Testosterone on day 3 (ng/mL) 0.19 ± 0.09 0.27 ± 0.43
Fasting plasma glucose (FPG, mg/dL) 81.8 ± 7.7 81.3 ± 7.0
Fasting serum insulin (FSI, μU/mL) 4.5 ± 1.9 4.1 ± 1.3
Hemoglobin A1c (%) 5.3 ± 0.2 5.2 ± 0.2
HOMA-Rb (μUg/dL2) 0.93 ± 0.44 0.83 ± 0.28
Insulinogenic index (II, dU/g) 1.02 ± 1.62 0.62 ± 3.02
Total cholesterol (TC, mg/dL) 198 ± 32 184 ± 29
Low-density lipoprotein cholesterol (LDL, mg/dL) 112 ± 24 99 ± 33
Triglycerides (TG, mg/dL) 71 ± 51 61 ± 24
Uric acid (UA, mg/dL) 4.3 ± 1.0 4.1 ± 0.7
  1. aNo significant differences were found between groups (Unpaired t test for BMI, systolic / diastolic blood pressure, FPG, FSI, and UA; Mann-Whitney U test for other charasteristics)
  2. bHomeostasis model assessment-insulin resistance index